about
Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatoninPrefrontal cortex, caloric restriction and stress during aging: studies on dopamine and acetylcholine release, BDNF and working memoryDysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiencyEffects of some synthetic kynurenines on brain amino acids and nitric oxide after pentylenetetrazole administration to rats.Characterization of nocturnal ultradian rhythms of melatonin in children with growth hormone-dependent and independent growth delay.Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.Melatonin and mitochondrial function.Mitochondrial regulation by melatonin and its metabolites.The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.Melatonin in antinociception: its therapeutic applications.Melatonin protects rats from radiotherapy-induced small intestine toxicity.Melatonin enhances neural stem cell differentiation and engraftment by increasing mitochondrial function.Melatonin: potential functions in the oral cavity.CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome.Melatonin, a potential therapeutic agent for smooth muscle-related pathological conditions and aging.Melatonin-mitochondria interplay in health and disease.Mitochondrial DNA and inflammatory diseases.Exercise and melatonin in humans: reciprocal benefits.Agomelatine in depressive disorders: its novel mechanisms of action.Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes.Argan oil-contained antioxidants for human mitochondria.Extrapineal melatonin: sources, regulation, and potential functions.Melatonin in the oral cavity: physiological and pathological implications.A review of the melatonin functions in zebrafish physiology.Melatonin and metabolic regulation: a review.Melatonin, clock genes and mitochondria in sepsis.The benefit of a supplement with the antioxidant melatonin on redox status and muscle damage in resistance-trained athletes.The benefits of four weeks of melatonin treatment on circadian patterns in resistance-trained athletes.Fluorination Effects on NOS Inhibitory Activity of Pyrazoles Related to Curcumin.Permeabilized myocardial fibers as model to detect mitochondrial dysfunction during sepsis and melatonin effects without disruption of mitochondrial network.Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin.Cell protective role of melatonin in the brain.Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice.Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthasesGenetic dissection of endothelial transcriptional activity of zebrafish aryl hydrocarbon receptors (AHRs).Prophylactic Role of Oral Melatonin Administration on Neurogenesis in Adult Balb/C Mice during REM Sleep Deprivation.Identification of mitochondrial deficits and melatonin targets in liver of septic mice by high-resolution respirometry.Prophylactic actions of melatonin in oxidative neurotoxicity.Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging.
P50
Q28271296-CBE43E03-4951-429B-84CE-04BF796729BDQ28580179-71C3B6D2-F029-4378-A509-944215BCCDAAQ28588893-102D6811-38BA-4C60-B6D7-255F3E1DF9CCQ30919491-43F94773-53E6-48B6-B1FA-1E3070530A2CQ32131591-39BE9ADE-F288-4CA4-A811-D2516A38323DQ34490511-15F3ADB0-8CD4-4668-9C93-2C8108EF5500Q35795778-4C91164D-D021-47FE-BF57-3FC050C24412Q35810574-5E802B34-F71A-4130-B02F-53E9DB1674BFQ35822596-154FBF30-C11C-4CDB-B9BB-87C72B5E9E77Q36067329-2BB60E07-EA76-4103-9C21-BF3236447D03Q36344749-EC010E63-E90F-46F8-9EDA-3299737C2119Q36351040-D2467633-53F6-460C-83ED-B03D2300CF52Q36835794-FFD8480A-7830-4CFE-98F5-E54817E3A87CQ37555654-D108283D-BD4D-43C6-9D83-06929982AC1EQ37799644-04B099C6-56A6-4828-9707-2C0062B6D906Q37829754-6E6C40FD-AFA2-40D1-AAEC-019196D8C8F0Q37898562-D42B2085-73CD-4DF4-938E-EC08378BBEF6Q37919169-CC0B1A9D-D612-4D6F-BBF1-8A29396942CBQ38049488-7E693373-583F-4EB1-9874-54468F87A1C3Q38058550-4F9B658A-82B6-4251-BC17-72E308E17E8EQ38087598-2E30B327-B741-4F27-8676-8B3404A89B31Q38189699-BC9A8E23-0FDB-46AA-B0B8-8E0D79F59441Q38199125-FB346B28-42B9-49B8-BBB5-F2480888B536Q38219607-359BC41B-CEB2-40D9-8F85-5C2AEBFD7255Q38248106-200E9E3B-7073-4F6A-BC01-513BB7DFA6B2Q38635632-D44DE9A9-263D-4EE6-AF20-48DEDF1E3846Q38963952-394C7451-1E97-41AC-8B10-DA7DE62B8687Q40548477-BADA89C9-941B-4B35-86FC-548258D82ECEQ40569105-DF71A004-9267-4A5A-9080-3A510F6CAC16Q40839400-FE85ED87-4610-4D0C-8E10-496E379A96E9Q40866395-B1153475-7E1D-42F0-BEE8-BA62B7A198B3Q40975753-DE18AE22-3DAF-433A-8B9D-3B9AA42B0118Q41183481-6EC1F410-3319-4629-9BB9-B7F316137CCCQ41363567-61C851DD-F475-4B7D-9445-B080AE1C7185Q41444912-E7B7B082-B07E-4ABF-9415-C9AFE272F431Q41488534-6DC0F5EE-B299-4F2C-BD20-A353A9B78603Q41603873-7651B5D0-C311-499B-82C4-809A73A60560Q41643085-EB89EEB5-5599-494F-B8D0-D65F0FD8D487Q42168350-564B986E-88AC-4393-A998-D071D9B782B8Q42476189-00A24DCE-9B11-407D-AAAC-1B219977445C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Darío Acuña-Castroviejo
@ast
Darío Acuña-Castroviejo
@en
Darío Acuña-Castroviejo
@es
Darío Acuña-Castroviejo
@sl
type
label
Darío Acuña-Castroviejo
@ast
Darío Acuña-Castroviejo
@en
Darío Acuña-Castroviejo
@es
Darío Acuña-Castroviejo
@sl
prefLabel
Darío Acuña-Castroviejo
@ast
Darío Acuña-Castroviejo
@en
Darío Acuña-Castroviejo
@es
Darío Acuña-Castroviejo
@sl
P1053
N-7456-2016
P106
P1153
35599413200
P21
P31
P3829
P496
0000-0002-9680-1560